Jani, R. H., Gupta, R., Bhatia, G., Rathi, G., Ashok Kumar, P., Sharma, R., . . . Mendiratta, S. K. (2015). A prospective, randomized, double‐blind, multicentre, parallel‐group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC‐3197) and adalimumab (Humira) in patients with rheumatoid arthritis. Int J Rheum Dis.

Jani, Rajendrakumar H., et al. "A Prospective, Randomized, Double‐blind, Multicentre, Parallel‐group, Active Controlled Study to Compare Efficacy and Safety of Biosimilar Adalimumab (Exemptia; ZRC‐3197) and Adalimumab (Humira) in Patients With Rheumatoid Arthritis." Int J Rheum Dis 2015.

Jani, Rajendrakumar H., et al. "A Prospective, Randomized, Double‐blind, Multicentre, Parallel‐group, Active Controlled Study to Compare Efficacy and Safety of Biosimilar Adalimumab (Exemptia; ZRC‐3197) and Adalimumab (Humira) in Patients With Rheumatoid Arthritis." Int J Rheum Dis 2015.